|
Editorial on the expanding enterprise-grade virtual care platforms for health systems. Leveraging a digital platform to support both acute and longitudinal healthcare needs exist in the market. Healthcare leaders must invest time in creating new practice flows. The first step is looking at the needs of the patient through the lens of a
consumer.
|
“COVID-19 Telehealth Impact Study, Exploring One Year of Telehealth Experimentation”
Hear perspectives on research findings and new MITRE Corporation National Strategy for Digital Health in the U.S. from leading clinicians Dr. Francis R. Campion, Principal Digital Health Analyst, The MITRE Corporation and Dr. Steve Ommen, Medical Director, Digital Products & Product/Platform Strategy,
Mayo Clinic, Rochester MN
Moderator: Tory Cenaj, Founder and Publisher of Telehealth and Medicine Today.
Click here to listen to the discussion.
|
Measuring the Early Impact of COVID-19 for Future Market and Policy Corrections in the United States
Click here for link to blog post.
|
To submit an original research manuscript visit:
Deadline for November TMT submissions: October 1, 2021.
|
CONV2X 2021 Symposium, November 9-11
|
Join 100 global market-guiding leaders at the acclaimed healthtech modernization symposium catalyzing C-suite executives driving critical initiatives for
policy, trust, access and low cost health solutions with telehealth and DLT at #ConV2X 2021.
The symposium is the premier destination community fostering consensus and partnership for trail blazing paths forward through ,real world evidence strategy, operations, research & trends to successfully navigate the new digital health era.
For ConV2X 2021 Agenda Topics, Registration, Proposal Submissions and more, visit conv2xsymposium.com
|
Telehealth and Medicine Today (TMT) is a gold open access international peer reviewed journal examining the value of telehealth and clinical automation, its use and scalable developments, business process guidance, market research and the
economic impact of digital health innovations in an evolving health technology sector. Articles feature original research, pilot studies, case use, best practices and perspectives from multidisciplinary stakeholders. Authors are encouraged to submit outcomes data for cost efficiencies realized in health system(s), patient populations or clinical practices in a value based system. A world-class review board includes constructive commentary through rapid and rigorous peer review. TMT timestamps article provenance on the blockchain.
TMT’s audience includes leadership at hospitals and medical research centers, universities, payor organizations, IT/IS, healthcare providers, consultants, companies (early and more established), entrepreneurs, developers & start-ups, life sciences and device companies, pharmacy, NGO, government, and policy leadership around the globe.
Endorsed by
|
Building Trust Through Truth
|
|
|
|